Abstract:Liprin‐α1 is a scaffold protein involved in cancer cell adhesion and invasion. We show that liprin‐α1 depletion significantly alters the response of HNSCC and breast cancer cells to MEK/ERK inhibitors and leads to increased p‐ERK levels and redistribution of RAS proteins to the cell membrane. Thus, liprin‐α1 is an important contributor to oncogenic RAS/MAPK signaling and a potential drug response indicator for MEK/ERK inhibitors. PTPRF interacting protein alpha 1 (PPFIA1) encodes for liprin‐α1, a member of the leukocyte common antigen–related protein tyrosine phosphatase (LAR‐RPTPs)‐interacting protein family. Liprin‐α1 localizes to adhesive and invasive structures in the periphery of cancer cells, where it modulates migration and invasion in head and neck squamous cell carcinoma (HNSCC) and breast cancer. To study the possible role of liprin‐α1 in anticancer drug responses, we screened a library of oncology compounds in cell lines with high endogenous PPFIA1 expression. The compounds with the highest differential responses between high PPFIA1‐expressing and silenced cells across cell lines were inhibitors targeting mitogen‐activated protein kinase kinase (MEK)/extracellular signal‐regulated kinases (ERK) signaling. KRAS proto‐oncogene, GTPase (KRAS)‐mutated MDA‐MB‐231 cells were more resistant to trametinib upon PPFIA1 knockdown compared with control cells. In contrast, liprin‐α1‐depleted HNSCC cells with low RAS activity showed a context‐dependent response to MEK/ERK inhibitors. Importantly, we showed that liprin‐α1 depletion leads to increased p‐ERK1/2 levels in all our studied cell lines independent of KRAS mutational status, suggesting a role of liprin‐α1 in the regulation of MAPK oncogenic signaling. Furthermore, liprin‐α1 depletion led to more pronounced redistribution of RAS proteins to the cell membrane. Our data suggest that liprin‐α1 is an important contributor to oncogenic RAS/MAPK signaling, and the status of liprin‐α1 may assist in predicting drug responses in cancer cells in a context‐dependent manner.

The role of liprin-α1 phosphorylation in its liquid-liquid phase separation: regulation by PPP2R5D/PP2A holoenzyme

Lipin-1 Contributes to IL-4 Mediated Macrophage Polarization

Liprin-α/RIM complex regulates the dynamic assembly of presynaptic active zones via liquid-liquid phase separation

The LDL receptor-related protein 1 (LRP1) regulates the PDGF signaling pathway by binding the protein phosphatase SHP-2 and modulating SHP-2- mediated PDGF signaling events

Mechanisms controlling membrane recruitment and activation of autoinhibited SHIP1

Mechanisms controlling membrane recruitment and activation of the autoinhibited SHIP1 inositol 5-phosphatase

Receptor Tyrosine Kinases Regulate Signal Transduction Through a Liquid-Liquid Phase Separated State

Liprin-α1 modulates cancer cell signaling by transmembrane protein CD82 in adhesive membrane domains linked to cytoskeleton

Comprehensive Regulation of Liquid–Liquid Phase Separation of Polypeptides

Lipidation alters the phase-separation of resilin-like polypeptides

Liquid–liquid Phase Separation in Diseases

Liprin-α3 controls vesicle docking and exocytosis at the active zone of hippocampal synapses

Opposing actions of JIP4 and RILPL1 provide antagonistic motor force to dynamically regulate membrane reformation during lysosomal tubulation/sorting driven by LRRK2

Liquid-liquid phase separation of proteins is modulated by amino acids in vitro and in vivo by regulating protein-protein interactions

Phase behaviour of hnRNPA1 low-complexity domain mutants described by different sequence-dependent models

The role of liquid-liquid phase separation in the disease pathogenesis and drug development

Liprin‐α1 contributes to oncogenic MAPK signaling by counteracting ERK activity

Role of Liquid-Liquid Phase Separation in Cell Fate Transition and Diseases

Acetylation of intrinsically disordered regions regulates phase separation

A conserved polybasic domain mediates plasma membrane targeting of Lgl and its regulation by hypoxia.

ORP5 localizes to ER–lipid droplet contacts and regulates the level of PI(4)P on lipid droplets